Concepedia

Lizhong Ding

LD

Statistics

Publications

3

Citations

133

H-Index

3

Active since

2023

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

University of California, Los Angeles

Lizhong Ding is an author at Parker Institute for Cancer Immunotherapy specializing in cancer immunotherapy, immunology, and oncology.

Publications per year

2023–2024

3

Publications

3

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

Richard G. Everson, Willy Hugo, Lu Sun et al. · Nature Communications · 2024 · 63 citations · Full text

, , +17

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Lu Sun, Jenny C. Kienzler, Jeremy Reynoso et al. · Journal of Clinical Investigation · 2023 · 46 citations · Full text

, , +17

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Lizhong Ding, Lu Sun, Melissa T. Bu et al. · Frontiers in Immunology · 2023 · 24 citations · Full text

, , +17

1–3 of 3